Clinical interventions in home care

2017 ◽  
pp. 223-228
Author(s):  
Gideon Caplan
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Home Care ◽  
Chronic Disease Management ◽  
Controlled Trial ◽  
Clinical Interventions ◽  
Disease Management Programmes ◽  
Healthcare Interventions ◽  
Meta Analyses ◽  
At Home

Healthcare interventions at home are vital for frail older people who frequently have difficulty accessing services. These clinical interventions include primary and secondary care, acute, subacute, and chronic disease management. Randomized controlled trial and meta-analyses have demonstrated improved health outcomes, such as decreased mortality, reduced hospitalization, and cost-effectiveness from many clinical interventions in home care, but not all. Hospital in the Home provides acute and subacute care at home across a wide range of diagnostic groups, whereas most chronic disease management programmes are disease specific. Improvements in and increased portability of technology has assisted many of these developments, but most home care remains proudly ‘high touch’. Ongoing improvements in technology hold the promise of greater benefits, but completely understanding the role of technological innovation in delivering improved outcomes cost effectively is a work in progress.

Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial

2018 ◽  
Vol 33 (9) ◽  
pp. 1634-1640 ◽  
Author(s):  
Alan J Wigg ◽  
Jong K Chin ◽  
Kate R Muller ◽  
Jeyamani Ramachandran ◽  
Richard J Woodman ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Chronic Disease ◽  
Cost Effectiveness ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Controlled Trial ◽  
Management Model ◽  
Randomized Controlled

scholarly journals Optimising patient active role with a user-centred eHealth platform (CONCERTO+) in chronic diseases management: a study protocol for a pilot cluster randomised controlled trial

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e028554 ◽  
Author(s):  
Marie-Pierre Gagnon ◽  
Mame Awa Ndiaye ◽  
Alain Larouche ◽  
Guylaine Chabot ◽  
Christian Chabot ◽  
...  
Keyword(s):  
Primary Care ◽  
Chronic Disease ◽  
Randomised Controlled Trial ◽  
Disease Management ◽  
Chronic Diseases ◽  
Chronic Disease Management ◽  
Controlled Trial ◽  
Cluster Randomised Controlled Trial ◽  
Cluster Randomised ◽  
Randomised Controlled

IntroductionMultimorbidity increases care needs and primary care use among people with chronic diseases. The Concerto Health Program (CHP) has been developed to optimise chronic disease management in primary care services. However, in its current version, the CHP primarily targets clinicians and does not aim to answer directly patients’ and their informal caregivers’ needs for chronic disease management. Various studies have shown that interventions that increase patient activation level are associated with better health outcomes. Furthermore, educational tools must be adapted to patients and caregivers in terms of health literacy and usability. This project aims to develop, implement and evaluate a user-centred, multifunctional and personalised eHealth platform (CONCERTO+) to promote a more active patient role in chronic disease management and decision-making.Methods and analysisThis project uses a collaborative research approach, aiming at the personalisation of CHP through three phases: (1) the development of one module of an eHealth platform based on scientific evidence and user-centred design; (2) a feasibility study of CONCERTO+ through a pilot cluster randomised controlled trial where patients with chronic diseases from a primary healthcare practice will receive CONCERTO+ during 6 months and be compared to patients from a control practice receiving usual care and (3) an analysis of CONCERTO+ potential for scaling up. To do so, we will conduct two focus groups with patients and informal caregivers and individual interviews with health professionals at the two study sites, as well as health care managers, information officers and representatives of the Ministry of Health.Ethics and disseminationThis study received ethical approval from Ethics Committee of Université Laval. The findings will be used to inform the effectiveness of CONCERTO+ to improve management care in chronic diseases. We will disseminate findings through presentations in scientific conferences and publication in peer-reviewed journals.Trial registration numberNCT03628963; Pre-results.

scholarly journals Reporting of Telehealth-Delivered Dietary Intervention Trials in Chronic Disease: Systematic Review (Preprint)

2017 ◽  
Author(s):  
Molly M Warner ◽  
Jaimon T Kelly ◽  
Dianne P Reidlinger ◽  
Tammy C Hoffmann ◽  
Katrina L Campbell
Keyword(s):  
Systematic Review ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Dietary Intervention ◽  
Controlled Trial ◽  
Mode Of Delivery ◽  
Delivery Mode ◽  
Intervention Component

BACKGROUND Telehealth-delivered dietary interventions are effective for chronic disease management and are an emerging area of clinical practice. However, to apply interventions from the research setting in clinical practice, health professionals need details of each intervention component. OBJECTIVE The aim of this study was to evaluate the completeness of intervention reporting in published dietary chronic disease management trials that used telehealth delivery methods. METHODS Eligible randomized controlled trial publications were identified through a systematic review. The completeness of reporting of experimental and comparison interventions was assessed by two independent assessors using the Template for Intervention Description and Replication (TIDieR) checklist that consists of 12 items including intervention rationale, materials used, procedures, providers, delivery mode, location, when and how much intervention delivered, intervention tailoring, intervention modifications, and fidelity. Where reporting was incomplete, further information was sought from additional published material and through email correspondence with trial authors. RESULTS Within the 37 eligible trials, there were 49 experimental interventions and 37 comparison interventions. One trial reported every TIDieR item for their experimental intervention. No publications reported every item for the comparison intervention. For the experimental interventions, the most commonly reported items were location (96%), mode of delivery (98%), and rationale for the essential intervention elements (96%). Least reported items for experimental interventions were modifications (2%) and intervention material descriptions (39%) and where to access them (20%). Of the 37 authors, 14 responded with further information, and 8 could not be contacted. CONCLUSIONS Many details of the experimental and comparison interventions in telehealth-delivered dietary chronic disease management trials are incompletely reported. This prevents accurate interpretation of trial results and implementation of effective interventions in clinical practice.

scholarly journals THE DIVERT-CARE CATALYST TRIAL: TARGETED CHRONIC-DISEASE MANAGEMENT FOR HOME CARE CLIENTS

2017 ◽  
Vol 1 (suppl_1) ◽  
pp. 322-323
Author(s):  
A.P. Costa ◽  
D. Haughton ◽  
G. Heckman ◽  
S. Bronskill ◽  
S. Sinha ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Home Care ◽  
Chronic Disease Management

scholarly journals Mortality of patients with COPD participating in chronic disease management programmes: a happy end?

Thorax ◽  
2014 ◽  
Vol 69 (9) ◽  
pp. 865-866 ◽  
Author(s):  
I Peytremann-Bridevaux ◽  
P Taffe ◽  
B Burnand ◽  
P O Bridevaux ◽  
M A Puhan
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Disease Management Programmes
Sign in / Sign up

Export Citation Format

Share Document